[Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015016:Yohimbine / Q000627:therapeutic use*
D015016:Yohimbine; D004877:Ergoloid Mesylates
Zur Beeinflussung arteriosklerotischer und hypertoner Hirngefäbbprozesse durch Raubasin und Dihydroergocristin.